Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00381446
Other study ID # MS005
Secondary ID
Status Recruiting
Phase N/A
First received September 25, 2006
Last updated September 26, 2007
Start date July 2005
Est. completion date March 2008

Study information

Verified date September 2007
Source Andrasko, Gary, OD, LLC
Contact Gary J. Andrasko, OD, MS
Phone 614-459-3363
Email gandrask@columbus.rr.com
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to quantify the amount of corneal staining observed with various marketed contact lens/multipurpose solution combinations. The hypothesis is that there are measurable differences in the amount of corneal staining between the various combinations.


Description:

A series of clinical studies is being conducted at one research site using a double-masked, randomized cross-over design. Each study consists of asymptomatic daily wear soft contact lens wearers observed at baseline and at two and four hours post lens insertion. Corneal staining is being assessed using sodium fluorescein, a cobalt filter and a yellow filter. Subjective comfort assessments are obtained at each visit.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date March 2008
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- currently wearing soft contact lenses daily wear for at least 2 weeks prior to study

- correct visual acuity of 20/30 or better each eye

Exclusion Criteria:

- history of hypersensitivity to any components of solution being tested

- any ocular condition prohibiting contact lens wear

- excessive baseline staining as defined in protocol

- use of topical or OTC ocular medications during the study

- seasonal allergies with significant effect on contact lens wear

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Marketed contact lens care products


Locations

Country Name City State
United States Dr. Richard Erdey office Columbus Ohio

Sponsors (2)

Lead Sponsor Collaborator
Andrasko, Gary, OD, LLC Alcon Research

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Area of Corneal Staining
Secondary Type (severity) of Corneal Staining
See also
  Status Clinical Trial Phase
Completed NCT02251561 - Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan N/A
Completed NCT01100424 - Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining N/A
Recruiting NCT05626478 - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery Phase 4
Completed NCT01240122 - Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions N/A
Completed NCT01335750 - A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand N/A
Completed NCT00518700 - Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients Phase 4
Completed NCT00483795 - Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining Phase 4